Letter to the Hon. Norman Sharpless, Acting Commissioner of the Food and Drug Administration - Bipartisan E&C Leaders Request FDA Briefing on Threat To U.S. Heparin Supply
Letter
Date: July 30, 2019
Issues: Health and Health Care